Healthcare
The HHS will limit the use of Bamlanivimab antibody treatments developed by Regeneron and Eli Lilly due to concerns the medications are not effective against these new strains.
Pennsylvania-based Ocugen has struck a deal to sell 100 million doses of a COVID-19 vaccine India’s Bharat Biotech in the United States later this year.
Topline results from a trial in Brazil show that treatment with Kintor’s proxalutamide cut mortality risk by 92% and significantly shortened the median length of hospital stay by nine days compared with standard of care in hospitalized patients with COVID-19.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 9, 2021.
Another study is adding to a growing body of literature that suggests convalescent plasma from recovered patients with COVID-19 doesn’t prevent further COVID-19 progression in at-risk people who visit the emergency room.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 2, 2021.
Perceptive Advisors’ fourth healthcare blank check company ARYA Sciences Acquisition IV announced it has raised up to $130 million through the offering of 13 million shares at $10.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 23, 2021.
Agilent is one of seven health care companies to make the fourth annual list of 100 companies compiled by the publication.
PRESS RELEASES